Jazz Pharmaceuticals
JAZZ | NASDAQ
$216.15
+$0.17 (+0.08%)
Nov 2, 2026, 2:34 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 1.21B | 1.07B | 1.2B | 1.13B | 1.05B | 897.84M | 1.09B | 1.05B | 1.02B | 901.98M | 1.01B | 972.14M | 957.32M | 892.81M | 972.12M | 940.65M | 932.88M | 813.72M | 896.73M | 838.12M | 751.81M | 607.58M |
Cost of Revenue | 116.4M | 306.4M | 24.65M | 257.76M | 116.27M | 104.62M | 128.71M | 111.61M | 109.9M | 95.49M | 107.24M | 102.15M | 97.54M | 128.64M | 167.36M | 133.66M | 124.21M | 115.28M | 136.15M | 145.22M | 119.19M | 40.19M |
Gross Profit | 1.09B | 762.5M | 1.17B | 868.35M | 929.44M | 793.22M | 959.46M | 943.36M | 913.92M | 806.5M | 904.69M | 869.99M | 859.78M | 764.17M | 804.76M | 806.99M | 808.67M | 698.44M | 760.58M | 692.89M | 632.62M | 567.39M |
Operating Income | 248.2M | 213.8M | 909.2M | 57.51M | -686.39M | -55.89M | 190.77M | 260.21M | 199.44M | 66.21M | 122.5M | 172.39M | 157.64M | 126.06M | -263.39M | 24.76M | 85.55M | 87.55M | 49.38M | 28.37M | -69.59M | 162.12M |
Interest Income | n/a | 23.4M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 211M | 299.2M | 208.28M | 9.04M | -735.55M | -110.35M | 133.2M | 200.52M | 137.92M | -2.95M | 61.07M | 99.64M | 80.12M | 54.1M | -340.77M | -62.68M | 18.55M | 2.18M | -47.82M | -70.89M | -134.7M | 139.85M |
Net Income | 192.8M | 293.1M | 203.45M | 251.41M | -718.47M | -92.54M | 191.12M | 215.06M | 168.57M | -14.62M | 94.15M | 146.82M | 104.44M | 69.42M | -239.95M | -19.65M | 34.67M | 1.65M | -35.35M | -52.83M | -363.32M | 121.83M |
Selling & General & Admin | 389.2M | 352.7M | 406.21M | 530.65M | 358.4M | 514.01M | 369.29M | 325.77M | 338.52M | 351.71M | 396.03M | 308.31M | 340.84M | 297.92M | 383.2M | 358.48M | 366.47M | 308.81M | 398.46M | 363.68M | 429.03M | 260.51M |
Research & Development | 207.5M | 134.1M | 171.41M | 240.7M | 189.97M | 180.65M | 240.5M | 199.92M | 220.73M | 222.85M | 216.61M | 234.4M | 209.24M | 189.41M | 172.56M | 148.87M | 139.05M | 129.98M | 155.44M | 141.04M | 132.7M | 76.57M |
Other Expenses | 247M | 61.9M | -313.54M | 39.49M | 1.07B | 154.45M | 158.9M | 157.46M | 155.22M | 165.73M | 169.55M | 154.88M | 152.06M | 150.79M | 512.39M | 274.88M | 217.6M | 172.09M | 157.29M | 159.8M | 140.48M | 68.19M |
Operating Expenses | 843.7M | 548.7M | 264.08M | 810.84M | 1.62B | 849.11M | 768.69M | 683.15M | 714.48M | 740.29M | 782.2M | 697.6M | 702.14M | 638.11M | 1.07B | 782.23M | 723.12M | 610.89M | 711.2M | 664.52M | 702.21M | 405.27M |
Interest Expense | 37.1M | 63.3M | 45.41M | 48.58M | 47.36M | 53.71M | 51.26M | 58.7M | 62.02M | 66.12M | 70.32M | 71.5M | 73.47M | 74.15M | 74.13M | 80.24M | 63.19M | 70.68M | 88.6M | 93.37M | 69.42M | 27.38M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 960.1M | 855.1M | 288.73M | 1.07B | 1.73B | 953.73M | 897.4M | 794.76M | 824.38M | 835.78M | 889.44M | 799.75M | 799.68M | 766.76M | 1.24B | 915.89M | 847.33M | 726.17M | 847.35M | 809.75M | 821.4M | 445.46M |
Income Tax Expense | 18.1M | 6.1M | 4.88M | -242.42M | -17.08M | -17.81M | -57.91M | -14.53M | -30.65M | 11.67M | -33.09M | -47.18M | -24.32M | -15.32M | -100.04M | -43.03M | -16.11M | 536K | -12.47M | -18.06M | 228.62M | 18.02M |
Shares Outstanding (Basic) | 63.2M | 61.9M | 60.98M | 60.7M | 61.19M | 60.98M | 60.54M | 61.41M | 62.88M | 62.54M | 62.58M | 63.11M | 63.99M | 63.49M | 63.05M | 62.79M | 62.44M | 61.87M | 61.5M | 61.28M | 59.45M | 56.47M |
Shares Outstanding (Diluted) | 69.4M | 66.1M | 60.98M | 61.61M | 61.19M | 60.98M | 61.5M | 63.17M | 69.63M | 62.54M | 69.67M | 71.29M | 73.54M | 73.77M | 63.05M | 62.79M | 63.43M | 62.91M | 61.5M | 61.28M | 59.45M | 58.39M |
EPS (Basic) | 3.05 | 4.73 | 3.28 | 4.14 | -11.74 | -1.52 | 3.16 | 3.50 | 2.68 | -0.23 | 1.50 | 2.33 | 1.63 | 1.09 | -3.81 | -0.31 | 0.56 | 0.03 | -0.57 | -0.86 | -6.11 | 2.16 |
EPS (Diluted) | 2.78 | 4.43 | 3.34 | 4.08 | -11.74 | -1.52 | 3.11 | 3.42 | 2.49 | -0.23 | 1.42 | 2.14 | 1.52 | 1.04 | -3.81 | -0.31 | 0.55 | 0.03 | -0.57 | -0.86 | -6.11 | 2.09 |
EBITDA | 418.1M | 543.9M | 278.56M | 235.86M | -514.18M | 138.86M | 396.98M | 424.46M | 362.97M | 268.53M | 393.75M | 333.7M | 313.16M | 344.87M | 411.44M | 296.93M | 317.2M | 340.8M | 517.45M | 190.06M | 82.04M | 235.09M |
EBIT | 248.1M | 362.5M | 253.69M | 57.61M | -688.19M | -26.01M | 228.56M | 259.22M | 199.94M | 105.15M | 234.55M | 171.14M | 153.59M | 187.51M | 266.71M | 148.1M | 160.99M | 161.09M | 352.83M | 22.48M | -65.28M | 162.12M |
Depreciation & Amortization | 170M | 181.4M | 24.87M | 178.25M | 174.01M | 164.87M | 168.42M | 165.23M | 163.04M | 163.38M | 159.2M | 162.56M | 159.58M | 157.36M | 144.73M | 148.83M | 156.2M | 179.71M | 164.62M | 167.58M | 147.32M | 72.97M |
Add to Watchlist
Select watchlists to add or remove JAZZ